FDA Recalls KleenFoam Antimicrobial Foam Soap for Bacterial Contamination
DermaRite Industries is recalling 6,973 cartridges of KleenFoam Antimicrobial Foam Soap due to contamination with Burkholderia cepacia bacteria.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification mandates a minimum severity of Severe. Although Burkholderia cepacia is a serious opportunistic pathogen, the source text does not report any illnesses or injuries.
Plain-English summary
DermaRite Industries, LLC is recalling KleenFoam Antimicrobial Foam Soap with Aloe Vera (Chloroxylenol 0.5%) in 34 FL OZ cartridges. The product was found to be contaminated with Burkholderia cepacia bacteria.
Approximately 6,973 cartridges are affected. The product was distributed nationwide in the United States. The affected product has NDC 61924-093-34. Multiple lot numbers are included in the recall, with expiration dates ranging from August 2025 through January 2027.
The recalled product
- Product
- KleenFoam, Antimicrobial Foam Soap with Aloe Vera, (Chloroxylenol 0.5%) 34 FL OZ (1000 mL) per cartridge, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-093-34
- Manufacturer
- DermaRite Industries, LLC
- Category
- Drug
- Hazard
- microbial-contamination
- burkholderia-cepacia
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: 30705A
- Exp. Date 8/2025
- 30771A
- Exp. Date 9/2025
- 30920A
- Exp. Date 10/2025
- 40016A
- Exp. Date 1/2026
- 40303A
- Exp. Date 4/2026
- 40428A
- Exp. Date 5/2026
- 40505A
- Exp. Date 6/2026
- 41053C
- 41053A
- 41053B
- Exp. Date 12/2026
- 50017A
- Exp. Date 1/2027.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27